Matthew Boersma is the Associate Director of FBRI where he works to enable innovative research and therapeutic development for neurodegenerative diseases and related disorders. He engages with multiple stakeholders to facilitate collaborations and information exchange to accelerate the pace of discovery. As part of this role, Matthew also collaborates closely with the F-Prime team and he previously worked with Alzforum to identify and develop new information resources for the neurodegeneration research community. Before joining FBRI, he was a postdoctoral research fellow at Boston Children’s Hospital and Harvard Medical School.

Matthew received a Ph.D. in neuroscience from the Johns Hopkins University School of Medicine and earned an A.B. in neuroscience from Bowdoin College.